NatWest


EPS upgrades on faster cost of risk normalisation

22/02/21 -"As announced in our post-release comments, we have upgraded our forecasts for 2021. This was fully driven by the sharply reduced loan impairments projections (down £1.4bn to £1.1bn), whereas we have ..."

Pages
59
Language
English
Published on
22/02/21
You may also be interested by these reports :
12/11/26
Third-quarter results showed an ongoing, albeit delayed, recovery in profitability. As a result, management downgraded its full-year profit guidance. ...

12/11/26
ABN delivered a strong but lower-quality Q3 beat, driven by NIBC badwill (€85m) and net provision releases, while fees missed. Underlying revenue ...

11/11/26
We continue to believe that Standard Chartered (REDUCE, UK) should be part of any bank portfolio, as a hedge against the implications of the ongoing ...

10/11/26
DNB’s CMD 2026 is a continuation plan: same three growth levers, 3-4% loan growth, above-9% fee CAGR and NOK4bn gross cost cuts, targeting above-15% ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO